MacroGenics | MGNX - Ebitda


MacroGenics reported $21.95M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 4.34B 56M Jun/2025
Amgen USD 5.91B 2.31B Sep/2025
AstraZeneca USD 4.96B 127M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Genmab DKK 477M 101M Sep/2025
Geron USD -7.55M 8.85M Jun/2025
Gilead Sciences USD 4.03B 628M Sep/2025
J&J USD 9.52B 389M Sep/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Xencor USD -30.52M 6.39M Jun/2025